Anebulo Pharmaceuticals Inc
ANEB2.700USD
-0.150-5.26%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
2.700USD+2.700After-hours (ET)
110.93MMarket Cap
LossP/E TTM
Anebulo Pharmaceuticals Inc
2.700
-0.150-5.26%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-6.98%-1.60M
22.49%-1.41M
38.02%-1.69M
27.95%-2.05M
31.64%-1.50M
30.49%-1.81M
-34.07%-2.73M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
-161.46%-2.03M
35.60%-2.00M
-19.62%-1.46M
---1.20M
---777.90K
---3.10M
---1.22M
Net income from continuing operations
-1.37%-1.68M
9.36%-2.46M
11.29%-2.20M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-7.44%-2.50M
-49.11%-2.80M
-256.66%-3.83M
-68.14%-2.61M
92.02%-2.32M
-237.60%-1.88M
---1.07M
---1.55M
---29.11M
---555.83K
Other non-cash items
310.72%245.18K
87.50%59.70K
--59.70K
--59.70K
--59.70K
--31.84K
----
----
----
----
----
----
100.00%0.00
--0.00
--0.00
--392.73K
---291.08K
Change in working capital
-672.47%-426.18K
-33.61%433.26K
135.93%164.13K
-62.82%-939.85K
-114.38%-55.17K
-34.21%652.56K
-224.80%-456.80K
-697.96%-577.23K
32.35%383.79K
550.78%991.91K
-50.63%366.01K
108.56%96.53K
170.03%289.97K
---220.04K
--741.32K
---1.13M
---414.06K
-Change in receivables
--30.76K
--214.61K
---245.36K
----
----
----
----
----
----
----
----
--0.00
--0.00
----
----
--0.00
--0.00
-Change in prepaid expenses
-211.48%-161.77K
-115.00%-53.33K
196.45%100.85K
-22.70%-190.11K
-119.59%-51.94K
417.10%355.57K
-124.36%-104.56K
53.08%-154.95K
4.31%265.11K
-79.64%68.76K
14.40%429.29K
69.32%-330.22K
145.16%254.14K
--337.72K
--375.25K
---1.08M
---562.81K
Cash from non-recurring investing activities
Cash from operating activities
-6.98%-1.60M
22.49%-1.41M
38.02%-1.69M
27.95%-2.05M
31.64%-1.50M
30.49%-1.81M
-34.07%-2.73M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
-161.46%-2.03M
35.60%-2.00M
-19.62%-1.46M
---1.20M
---777.90K
---3.10M
---1.22M
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
---116.66K
24156.20%15.00M
----
100.00%0.00
--0.00
74.95%-62.35K
-100.00%0.00
---68.16K
--0.00
---248.93K
--6.70M
-100.00%0.00
-100.00%0.00
----
----
--19.78M
--2.05M
Net cash flow from debt Issuance/repayment
----
----
----
----
----
----
----
----
----
----
----
--0.00
100.00%0.00
----
----
--0.00
---201.29K
Net cash flow from common stock issuance/repurchase
--0.00
--15.00M
----
----
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--6.70M
----
----
----
----
--20.60M
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
----
--2.25M
Proceeds from issuance of warrants
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--2.25M
----
Net cash flow from other financing activities
---116.66K
----
----
100.00%0.00
--0.00
74.95%-62.35K
----
---68.16K
--0.00
---248.93K
----
----
----
----
----
---3.07M
----
Net cash from non-recurrent financing activities
Net cash from financing activities
---116.66K
24156.20%15.00M
----
100.00%0.00
--0.00
74.95%-62.35K
-100.00%0.00
---68.16K
--0.00
---248.93K
--6.70M
-100.00%0.00
-100.00%0.00
----
----
--19.78M
--2.05M
Net cash flow
Beginning cash balance
125.73%15.00M
-83.52%1.40M
-72.49%3.09M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-14.40%14.16M
-9.18%16.36M
0.03%19.21M
-27.21%14.55M
400.37%16.55M
626.17%18.01M
--19.21M
--19.99M
--3.31M
--2.48M
Current period cash flow changes
-14.77%-1.72M
824.62%13.59M
38.02%-1.69M
29.63%-2.05M
31.64%-1.50M
34.37%-1.88M
-158.45%-2.73M
-45.92%-2.92M
-49.91%-2.19M
-138.44%-2.86M
699.72%4.67M
-111.99%-2.00M
-276.68%-1.46M
---1.20M
---777.90K
--16.68M
--827.08K
Ending cash balance
158.01%13.28M
125.73%15.00M
-83.52%1.40M
-72.49%3.09M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-14.40%14.16M
-9.18%16.36M
0.03%19.21M
-27.21%14.55M
400.37%16.55M
--18.01M
--19.21M
--19.99M
--3.31M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
